AU8005201A - Pharmaceutical composition comprising an analgesic peptide - Google Patents

Pharmaceutical composition comprising an analgesic peptide

Info

Publication number
AU8005201A
AU8005201A AU8005201A AU8005201A AU8005201A AU 8005201 A AU8005201 A AU 8005201A AU 8005201 A AU8005201 A AU 8005201A AU 8005201 A AU8005201 A AU 8005201A AU 8005201 A AU8005201 A AU 8005201A
Authority
AU
Australia
Prior art keywords
amino acid
pharmaceutical composition
peptide
trp
null
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU8005201A
Other languages
English (en)
Inventor
Aharon Shulov
Naftali Primor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHLOMIT SHULOV BARKAN
Shulov Institute for Science (SIS) Ltd
Original Assignee
SHLOMIT SHULOV BARKAN
Shulov Institute for Science (SIS) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHLOMIT SHULOV BARKAN, Shulov Institute for Science (SIS) Ltd filed Critical SHLOMIT SHULOV BARKAN
Publication of AU8005201A publication Critical patent/AU8005201A/xx
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0825—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Glp-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU8005201A 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide Pending AU8005201A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL137820A IL137820A (en) 2000-08-10 2000-08-10 Pharmaceutical composition for topical administration comprising an analgesic peptide
PCT/IL2001/000724 WO2002012269A2 (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide

Publications (1)

Publication Number Publication Date
AU8005201A true AU8005201A (en) 2002-02-18

Family

ID=11074512

Family Applications (2)

Application Number Title Priority Date Filing Date
AU8005201A Pending AU8005201A (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide
AU2001280052A Expired AU2001280052B2 (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2001280052A Expired AU2001280052B2 (en) 2000-08-10 2001-08-06 Pharmaceutical composition comprising an analgesic peptide

Country Status (12)

Country Link
US (1) US7220725B2 (enExample)
EP (1) EP1309613B1 (enExample)
JP (1) JP4860096B2 (enExample)
CN (2) CN1462277A (enExample)
AT (1) ATE392428T1 (enExample)
AU (2) AU8005201A (enExample)
CA (1) CA2418793C (enExample)
DE (1) DE60133654T2 (enExample)
DK (1) DK1309613T3 (enExample)
ES (1) ES2305096T3 (enExample)
IL (1) IL137820A (enExample)
WO (1) WO2002012269A2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
JP2008537739A (ja) * 2005-03-21 2008-09-25 ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク 新規神経疼痛経路
CA2681593A1 (en) * 2007-03-23 2008-10-02 Nisshin Pharma Inc. Preventive or therapeutic composition for liver disease
KR20110060940A (ko) * 2008-09-22 2011-06-08 닛신 파마 가부시키가이샤 항염증성 펩티드
DK2459183T3 (en) 2009-07-27 2016-01-18 Nocicepta Llc Methods for the treatment of pain
FR2948809B1 (fr) * 2009-07-31 2012-08-17 St Microelectronics Rousset Amplificateur de lecture faible puissance auto-minute
MX2013011219A (es) 2011-03-28 2013-10-17 S I S Shulov Innovative Science Ltd Metodo para el tratamiento de trastornos de la piel.
HRP20231438T1 (hr) 2015-01-07 2024-06-07 Tonix Pharma Limited Formulacije oksitocina koje sadrže magnezij i načini uporabe
CN115814055A (zh) 2016-04-12 2023-03-21 三叉神经股份公司 含镁催产素制剂和应用方法
RU2669386C1 (ru) * 2017-08-11 2018-10-11 Закрытое акционерное общество "Институт экспериментальной фармакологии" Состав и способ получения анальгетического средства пептидной структуры
AU2019245521B2 (en) * 2018-03-29 2024-10-31 S.I.S Shulov Innovative Science Ltd. Pharmaceutical compositions for inhibiting inflammatory cytokines
US11644463B2 (en) * 2019-08-30 2023-05-09 Euroimmun Medizinische Labordiagnostika Ag Detection of an autoantibody
CA3155594C (en) 2019-09-26 2025-06-17 S.I.S. Shulov Innovative Science Ltd. Topical anti-aging compositions containing a tetrapeptide
WO2021059267A1 (en) * 2019-09-26 2021-04-01 S.I.S. Shulov Innovative Science Ltd. Compositions and methods for treating degenerative, age-related and trauma-induced disorders

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4491541A (en) * 1982-11-10 1985-01-01 Farmitalia Carlo Erba Peptides
IT1172391B (it) * 1983-12-23 1987-06-18 Polifarma Spa Composti tirpeptidici contenenti acido piroglutaminico e triptofano,procedimentio di produzione ed applicazioni terapeutiche
JPH0680079B2 (ja) * 1984-11-09 1994-10-12 エーザイ株式会社 ポリペプチド
IT1242002B (it) * 1990-10-03 1994-02-02 Polifarma Spa Composti con attivita' farmacologica antiipertensiva, analgesica, immunomodulante e antiinfiammatoria, che presentano nella molecola una sequenza di tre radicali, essendo alfa-amminoacido quello centrale
AU1907292A (en) 1991-04-24 1992-12-21 Warner-Lambert Company Alpha-substituted polypeptides having therapeutic activity
AUPM489194A0 (en) * 1994-04-07 1994-04-28 Luminis Pty Limited Peptides
RU2107691C1 (ru) * 1995-03-02 1998-03-27 Дейгин Владислав Исакович Пептид и способ его получения
US5776896A (en) * 1996-01-03 1998-07-07 Zeneca Limited Analgesic peptides from venom of grammostola spatulata and use thereof
CA2256365A1 (en) * 1996-05-22 1997-11-27 Diversified Pharmaceuticals, Inc. Compositions, methods and devices for the transdermal delivery of drugs
US6126939A (en) * 1996-09-03 2000-10-03 Yeda Research And Development Co. Ltd. Anti-inflammatory dipeptide and pharmaceutical composition thereof
IL123001A (en) * 1998-01-20 1998-12-06 Shulov Inst For Venom Research Analgesic fraction from snake March and pharmacy preparations containing it
CA2341810A1 (en) * 1998-08-28 2000-03-09 Myelos Corporation Cyclic prosaposin-derived peptides and uses thereof
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide

Also Published As

Publication number Publication date
WO2002012269A2 (en) 2002-02-14
CN102160890A (zh) 2011-08-24
CA2418793A1 (en) 2002-02-14
ES2305096T3 (es) 2008-11-01
WO2002012269A3 (en) 2002-12-19
HK1160778A1 (en) 2012-08-17
US20040014673A1 (en) 2004-01-22
DK1309613T3 (da) 2008-08-11
DE60133654D1 (de) 2008-05-29
ATE392428T1 (de) 2008-05-15
CN102160890B (zh) 2013-02-06
JP4860096B2 (ja) 2012-01-25
AU2001280052B2 (en) 2007-11-29
CA2418793C (en) 2011-11-15
IL137820A0 (en) 2001-10-31
EP1309613B1 (en) 2008-04-16
CN1462277A (zh) 2003-12-17
JP2004513079A (ja) 2004-04-30
US7220725B2 (en) 2007-05-22
DE60133654T2 (de) 2009-06-04
IL137820A (en) 2009-06-15
EP1309613A2 (en) 2003-05-14

Similar Documents

Publication Publication Date Title
AU8005201A (en) Pharmaceutical composition comprising an analgesic peptide
WO2002047715A3 (en) Compositions of peptide crystals
Ljungqvist et al. Antide and related antagonists of luteinizing hormone release with long action and oral activity.
CA2370289A1 (en) Neuronal exocytosis inhibiting peptides and cosmetic and pharmaceutical compositions containing said peptides
AU2000277238A1 (en) Non-mammalian gnrh analogs and uses thereof in tumor cell growth regulation and cancer therapy
US4742156A (en) Peptide antagonists of neurokinin B and opthalmic solutions containing them
CA2596597A1 (en) Method for stimulation collagen synthesis and/or kgf expression
IE57698B1 (en) Modified protease inhibitors,process for their preparation,and pharmaceutical compositions prepared therefrom
MY139203A (en) Pharmaceutical composition
AU1377092A (en) Peptides for treatment
JP2004513079A5 (enExample)
DK1173476T3 (da) Funktionelle sojabönneproteiner
AU2003292326A1 (en) Cosmetic or pharmaceutical composition comprising peptides with the sequence arg-gly-ser
EP0219258A2 (en) Peptide antagonists of Neurokinin B and opthalmic solutions containing them
NO952635L (no) Syntetiske peptidderivater og salter derav
RU93050068A (ru) Циклопептиды, способ их получения, фармацевтические композиции и способ их получения, способ лечения
WO2004028457A3 (en) PHARMACEUTICAL COMPOSITION FOR IMPROVED ADMINISTRATION OF HIV gp41-DERIVED PEPTIDES, AND ITS USE IN THERAPY
CA2102447A1 (en) Cyclopeptides
CA2423004A1 (en) Peptide inhibitors of hiv entry
AU2001266441A1 (en) Tetrapeptide stimulating functional activity of hepatocytes and its therapeutical use
RU95120588A (ru) Циклогексапептиды, их смеси, способ их получения и применения
KR101410589B1 (ko) 뉴로펩타이드 유도체 및 이를 함유하는 피부 외용제 조성물
JP2023519935A (ja) 皮膚症状に用いるためのアセチルコリンエステラーゼのｃ末端に由来するポリペプチド
US5593965A (en) Anti-tumor effects of GnRH-III
US4948873A (en) Gonadoliberine analogues of high activity